Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (1113)	9/17/1998 8:00:00 PM
From: Saul H Rosenthal	Read Replies (1) \| Respond to of 1432

People wonder why it is up. Several reasons. It is getting close to time for approval, no one expects it to not be approved, there is more and more trouble with albumin (which increases BTIM's market), Baxter's product dropped out (even though it is not strictly a competitor), mutual funds are starting to get interested, BTIM is about to file for approval in Europe too, there is NO bad news and there is a huge position short that can't be covered without pushing the price up 10-15 points, the shorts are playing chicken with each other because they all can't fit through the door at once. It is a classic set-up!